Velan Capital Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$46.4K	Sell	32,700 -2,300	-7%	-$3.27K	0.05%	45
2025 Q1	$53.6K	Buy	35,000 +8,000	+30%	+$12.2K	0.06%	38
2024 Q4	$67K	Buy	+27,000	New	+$67K	0.06%	33
2024 Q1	–	Sell	-1,761,595	Closed	-$1.85M	–	20
2023 Q4	$1.85M	Buy	+1,761,595	New	+$1.85M	1.08%	14